Recent News

• 05.07.2026 - Inogen Announces First Quarter 2026 Financial Results
• 04.23.2026 - Inogen to Report First Quarter 2026 Financial Results on May 7, 2026
• 04.06.2026 - Inogen Announces the Appointment of Vafa Jamali to Board of Directors
• 03.31.2026 - Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
• 03.30.2026 - Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.30.2026 - Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth
• 03.05.2026 - Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum

Recent Filings

• 05.04.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 04.28.2026 - ARS Annual Report to Security Holders
• 04.28.2026 - DEF 14A Other definitive proxy statements
• 04.17.2026 - PRE 14A Other preliminary proxy statements
• 04.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.08.2026 - 3 Initial statement of beneficial ownership of securities
• 04.06.2026 - EX-99.1 EX-99.1
• 04.06.2026 - 8-K Current report
• 03.30.2026 - EX-99.1 EX-99.1
• 03.30.2026 - 8-K Current report